Search research articles
Contact Us
Filters
Showing results (501-510 of 647) with videos related to
Page
of 65
Sort By:
Journal of Hazardous Materials
|
November 20, 2019
Contamination of N-poor wastewater with emerging pollutants does not affect the performance of purple phototrophic bacteria and the subsequent resource recovery potential
I de Las Heras, R Molina, Y Segura, et al.
Anticancer Research
|
September 2, 1999
C-erbB-2, CEA and CA 15.3 serum levels in the early diagnosis of recurrence of breast cancer patients
R Molina, J Jo, X Filella, et al.
Revista Medica De Chile
|
February 14, 2014
[Prevalence of Gilbert syndrome and its genetic determinants in Chile]
Luis Méndez, Marcela Lagoa, Teresa Quiroga, et al.
British Journal of Cancer
|
October 1, 1996
Utility of C-erbB-2 in tissue and in serum in the early diagnosis of recurrence in breast cancer patients: comparison with carcinoembryonic antigen and CA 15.3
R Molina, J Jo, G Zanón, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
September 3, 2010
Phase I/II study of AT-101 with topotecan in relapsed and refractory small cell lung cancer
Rebecca Suk Heist, Jerry Fain, Bernard Chinnasami, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
December 5, 2003
Tumor markers (CEA, CA 125, CYFRA 21-1, SCC and NSE) in patients with non-small cell lung cancer as an aid in histological diagnosis and prognosis. Comparison with the main clinical and pathological prognostic factors
R Molina, X Filella, J M Augé, et al.
Archivos Espanoles De Urologia
|
May 24, 2012
Impossible bladder catheter removal. What can we do?
R Molina Escudero, F Herranz Amo, E Lledo Garcia, et al.
Environment International
|
February 7, 2012
Drugs of abuse in surface and tap waters of the Tagus River basin: heterogeneous photo-Fenton process is effective in their degradation
Y Valcárcel, F Martínez, S González-Alonso, et al.
Human Pathology
|
September 10, 2019
Loss of ATRX expression predicts worse prognosis in pulmonary carcinoid tumors
Simone B S P Terra Md, Hao Xie Md PhD, Jennifer M Boland Md, et al.
Investigational New Drugs
|
April 25, 2020
A phase I study of the VEGFR kinase inhibitor vatalanib in combination with the mTOR inhibitor, everolimus, in patients with advanced solid tumors
Mojun Zhu, Julian R Molina, Grace K Dy, et al.
Page
of 65
Search research articles
Search
Showing results (501-510 of 647) with videos related to
Sort By:
Page
of 65
Journal of Hazardous Materials
|
November 20, 2019
Contamination of N-poor wastewater with emerging pollutants does not affect the performance of purple phototrophic bacteria and the subsequent resource recovery potential
I de Las Heras, R Molina, Y Segura, et al.
Anticancer Research
|
September 2, 1999
C-erbB-2, CEA and CA 15.3 serum levels in the early diagnosis of recurrence of breast cancer patients
R Molina, J Jo, X Filella, et al.
Revista Medica De Chile
|
February 14, 2014
[Prevalence of Gilbert syndrome and its genetic determinants in Chile]
Luis Méndez, Marcela Lagoa, Teresa Quiroga, et al.
British Journal of Cancer
|
October 1, 1996
Utility of C-erbB-2 in tissue and in serum in the early diagnosis of recurrence in breast cancer patients: comparison with carcinoembryonic antigen and CA 15.3
R Molina, J Jo, G Zanón, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
September 3, 2010
Phase I/II study of AT-101 with topotecan in relapsed and refractory small cell lung cancer
Rebecca Suk Heist, Jerry Fain, Bernard Chinnasami, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
December 5, 2003
Tumor markers (CEA, CA 125, CYFRA 21-1, SCC and NSE) in patients with non-small cell lung cancer as an aid in histological diagnosis and prognosis. Comparison with the main clinical and pathological prognostic factors
R Molina, X Filella, J M Augé, et al.
Archivos Espanoles De Urologia
|
May 24, 2012
Impossible bladder catheter removal. What can we do?
R Molina Escudero, F Herranz Amo, E Lledo Garcia, et al.
Environment International
|
February 7, 2012
Drugs of abuse in surface and tap waters of the Tagus River basin: heterogeneous photo-Fenton process is effective in their degradation
Y Valcárcel, F Martínez, S González-Alonso, et al.
Human Pathology
|
September 10, 2019
Loss of ATRX expression predicts worse prognosis in pulmonary carcinoid tumors
Simone B S P Terra Md, Hao Xie Md PhD, Jennifer M Boland Md, et al.
Investigational New Drugs
|
April 25, 2020
A phase I study of the VEGFR kinase inhibitor vatalanib in combination with the mTOR inhibitor, everolimus, in patients with advanced solid tumors
Mojun Zhu, Julian R Molina, Grace K Dy, et al.
Page
of 65